Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance
CCP test may be a useful tool to estimate the risk of progression in PCa patients and guide the decision between AS and active treatment. Triple hit phenotype or TMPRSS:ERG fusion status was not associated with progression.
Authors
- Claudia Filippini (ORCID: https://orcid.org/0000-0003-0194-142X)
- Luisa Delsedime (ORCID: https://orcid.org/0000-0002-3564-598X)
- Ian Marc Bonapace (ORCID: https://orcid.org/0000-0001-6580-8893)
- Giovanni Luigi Capella (ORCID: https://orcid.org/0000-0002-5857-9073)
- Marco Oderda
- Gabriele Montefusco
- Donatella Pacchioni
- Paolo Gontero (ORCID: https://orcid.org/0000-0002-9714-6596)
- Giulia Orlando (ORCID: https://orcid.org/0000-0002-8917-0246)
- Giorgio Calleris (ORCID: https://orcid.org/0000-0003-3831-1632)
- D. D’Agate
- Paola Francia di Celle
- Eleonora Duregon (ORCID: https://orcid.org/0000-0003-4018-3983)
- Mauro Papotti
- Zaibunnisa Zaibunnisa
Institutions
- University of Insubria (IT)
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- University of Turin (IT)
Publication Details
- Journal
- The Prostate
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1002/pros.24921
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fondazione CRT